Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Rubius Therapeutics, Inc. | a18-9414_9ex5d1.htm |
| S-1MEF - S-1MEF - Rubius Therapeutics, Inc. | a18-9414_9s1mef.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated April 13, 2018 relating to the financial statements, which appears in Amendment No. 2 to the Registration Statement on Form S-1 (No. 333-225840) of Rubius Therapeutics, Inc. We also consent to the reference to us under the heading “Experts” in Amendment No. 2 to the Registration Statement on Form S-1 (No. 333-225840) incorporated by reference in this Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
July 17, 2018